Stock Selection: Grok 4's picks for 2026-10-14
Grok 4 picked LQDA, BSP, XLE, HALO, VLO for a 1-day horizon. Portfolio return vs SPY: +2.35%. Picks that beat SPY: 60%.
| Experiment | Stock Selection |
|---|---|
| Model | Grok 4 |
| Prompt version | stock-selection-v8 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-14 |
| Measured to | 2026-10-15 |
| Benchmark | SPY |
| Status | Settled |
| Portfolio return vs SPY | +2.35% |
| Picks that beat SPY | 60% |
| Benchmark return | -0.16% |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | LQDA | +1.63% | 72% | +1.79% | Yes |
| 2 | BSP | +8.92% | 68% | +9.08% | Yes |
| 3 | XLE | -0.89% | 65% | -0.73% | No |
| 4 | HALO | +2.99% | 62% | +3.15% | Yes |
| 5 | VLO | -1.68% | 60% | -1.52% | No |
The model's market view
Hotter-than-expected September CPI (headline 3.7% YoY) pushed Treasury yields higher and raised October Fed hike odds, sending SPY lower intraday while energy held up on elevated oil and geopolitical supply risks. Chip weakness persisted on Chinese competition news. Specific company catalysts and energy exposure offer the clearest paths to relative outperformance over the next session.
Why each pick
LQDA
Liquidia surged on the global settlement of all litigation with United Therapeutics, removing a major overhang and securing uninterrupted access to Yutrepia. Momentum from the large gap higher and elevated volume can persist into the next session relative to a soft SPY. Risks include profit-taking after a 25-30% move and broader risk-off from higher yields.
BSP
Bending Spoons jumped sharply on news of an additional Berkshire Hathaway investment of roughly $330 million, reinforcing confidence in the software platform after a prior stake. Fresh positive capital-allocation news can support continued relative strength versus SPY. Risks are high volatility typical of recent IPOs and potential fade if broader tech remains under pressure from rate fears.
XLE
Energy Select Sector SPDR has been the relative leader amid elevated crude prices driven by Middle East tensions and Houthi attacks. Sector resilience against the CPI-driven equity sell-off positions XLE to continue outperforming SPY on any further oil support or risk-premium persistence. Risks include a sudden geopolitical de-escalation or profit-taking after recent gains.
HALO
Halozyme advanced on a TD Cowen price-target raise to $130 and continued ENHANZE platform momentum. Biotech names with concrete analyst upgrades have shown relative strength even as the broader market digested hotter inflation. Risks are sector rotation away from growth if yields keep climbing and any disappointment on upcoming catalysts.
VLO
Valero has participated in the refining strength tied to elevated crack spreads and oil prices. As a pure-play refiner it offers leveraged exposure to the same energy tailwinds supporting XLE while trading with solid liquidity. Risks include crude price volatility and sensitivity to any shift in refining margins or broader equity weakness.
Other models on the same run
| Model | Picks | Portfolio return vs SPY | Picks that beat SPY |
|---|---|---|---|
| GPT-6 | XLE, XOM, TSM, BLK, XLP | +0.15% | 40% |
| Muse Spark 1.1 | AAPL, XLV, GOOGL, MSFT, NVDA | -0.11% | 40% |
| Gemini 3 Pro | NVDA, TSLA, AAPL, AMZN, MSFT | -0.94% | 20% |
| Perplexity | VLO, DINO, XLE, LQDA, JPM | -0.34% | 40% |
| DeepSeek | LQDA, ENVX, VIR, BABA, ASML | -0.57% | 40% |
Written up on ForecastNest Insights: Stock Selection: Grok 4's picks for 2026-10-14.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.